After finishing at $1.39 in the prior trading day, X4 Pharmaceuticals Inc (NASDAQ: XFOR) closed at $1.41, up 1.44%. In other words, the price has increased by $+0.0200 from its previous closing price. On the day, 2081070 shares were traded.
Ratios:
Our goal is to gain a better understanding of XFOR by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.34 and its Current Ratio is at 5.34. In the meantime, Its Debt-to-Equity ratio is 1.14 whereas as Long-Term Debt/Eq ratio is at 1.12.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, B. Riley Securities on December 12, 2023, Downgraded its rating to Neutral and sets its target price to $1 from $3 previously.
On December 22, 2022, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $3.Cantor Fitzgerald initiated its Overweight rating on December 22, 2022, with a $3 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 11 ’24 when Mostafa Adam S. sold 52,500 shares for $0.88 per share. The transaction valued at 46,347 led to the insider holds 0 shares of the business.
Ragan Paula sold 49,678 shares of XFOR for $43,856 on Mar 11 ’24. The President and CEO now owns 765,068 shares after completing the transaction at $0.88 per share. On Mar 11 ’24, another insider, DiBiase Mary, who serves as the Chief Operating Officer of the company, sold 15,409 shares for $0.88 each. As a result, the insider received 13,591 and left with 291,752 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, XFOR now has a Market Capitalization of 236.79M and an Enterprise Value of 180.86M.
Stock Price History:
Over the past 52 weeks, XFOR has reached a high of $2.58, while it has fallen to a 52-week low of $0.57. The 50-Day Moving Average of the stock is 0.9496, while the 200-Day Moving Average is calculated to be 1.1297.
Shares Statistics:
The stock has traded on average 2.00M shares per day over the past 3-months and 5.45M shares per day over the last 10 days, according to various share statistics. A total of 167.43M shares are outstanding, with a floating share count of 121.91M. Insiders hold about 27.41% of the company’s shares, while institutions hold 35.95% stake in the company. Shares short for XFOR as of Mar 15, 2024 were 14.22M with a Short Ratio of 7.10, compared to 13.23M on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 8.49% and a Short% of Float of 8.52%.
Earnings Estimates
Its stock is currently analyzed by 6 different market analysts. On average, analysts expect EPS of -$0.15 for the current quarter, with a high estimate of -$0.13 and a low estimate of -$0.18, while EPS last year was -$0.16. The consensus estimate for the next quarter is -$0.01, with high estimates of $0.36 and low estimates of -$0.2.
Analysts are recommending an EPS of between -$0.06 and -$0.75 for the fiscal current year, implying an average EPS of -$0.45. EPS for the following year is -$0.46, with 6 analysts recommending between -$0.07 and -$0.64.
Revenue Estimates
Based on 6 analysts’ estimates, the company’s revenue will be $62.02M in the next fiscal year. The high estimate is $163.1M and the low estimate is $4.27M. The average revenue growth estimate for next year is up 266.30% from the average revenue estimate for this year.
